Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05887674

Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease

Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease: Combined Low Inflammatory-index Diet, Physical Exercises, and Cognitive Training in Nursing Home

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
60 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study is a multicentre, randomized, double-blind, controlled trial that aims to investigate the efficacy of multi-domain life-style intervention including low inflammatory-index diet, exercise, and cognitive training in patients with mild cognitive impairment and mild Alzheimer's disease.

Detailed description

This is a multicentre, randomized, double-blind, controlled trial that aims to investigate the efficacy of multi-domain life-style intervention including low inflammatory-index diet, exercise, and cognitive training in patients with mild cognitive impairment and mild Alzheimer's disease. Patients who eligible to the inclusion criteria and ineligible to the exclusion criteria will be randomly assigned into three groups by a 1:1:1 ratio. Patients in first arm will receive multi-domain life-style intervention including low inflammatory-index diet, exercise, and cognitive training. Patients in the second arm will receive intervention of exercise and cognitive training. Patients in the third arm will receive regular health advice. We hypothesize that the multi-domain intervention will reduce impairment in the study group compared to the control group during the 2-year intervention period.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDiet interventionLow inflammatory-index diet
BEHAVIORALExerciseGuided muscle strength training and stretching exercises
BEHAVIORALCognitive trainingCognitive training will be implemented in person

Timeline

Start date
2023-05-11
Primary completion
2026-08-30
Completion
2026-08-30
First posted
2023-06-05
Last updated
2024-11-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05887674. Inclusion in this directory is not an endorsement.